Get notified when SLS files again. Create a free account and we'll email you the moment its next filing is analyzed.

Get filing alerts
NASDAQ: SLS SELLAS Life Sciences Group, Inc. 8-K

SELLAS raises $28.7M from warrant exercises, boosting cash to ~$136M

Filed June 2, 2026 · Period ending June 2, 2026 · ~1 min read

Key Changes

  • high

    Company received $28.7 million in April-May 2026 from warrant holders exercising rights to purchase common stock, increasing total cash position to approximately $135.8 million from $107.1 million at March 31.

  • medium

    Share count increased to 196.6 million shares outstanding as of June 2, 2026, reflecting dilution from warrant conversions into common equity.

This preview is just the start — the full report includes the narrative summary, section-by-section diffs against the prior filing, and verbatim quotes with EDGAR citations.

Read 3 full reports/month free No card required. Takes 30 seconds.

Want to see a complete report first? Today's free report (PXED 10-Q) is open in full — no account needed.

Partner

Trade SLS commission-free

Open an account, get a free stock.

Sign up

Investing involves risk. Free stock terms apply.

Was this report useful?

Source-verified from EDGAR · Narrative written by AI · Jun 3, 2026 · How we verify